Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Acorda Therapeutics announces Hatch-Waxman extension of AMPYRA® (dalfampridine) sustained-release formulation patent
Episode 25 with actor and science advocate Alan Alda discussing communicating science
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
The endocannabinoid system and multiple sclerosis.
Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression.
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
12th International Conference on Myasthenia Gravis and Related Disorders
Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach?
American Academy of Neurology Annual Meeting
Episode 2 with Dr. Barbara Koppel on recommendations for cannabis in MS
Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
Rapid, sustained and reversible pharmacodynamics of DAC HYP in MS patients supports mechanism of action via modulation of the IL-2 pathway
[Flow cytometry model for the detection of neutralizing antibodies against of IFN-β].
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
BRIEF: Teva files for Copaxone-Laquinimod patent
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
Defining the Role of Physiotherapy in Palliative Care in Multiple Sclerosis.
World Congress of Neurology (WCN) 2015

Pages